A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma

SIMPLE SUMMARY: New treatments in multiple myeloma are embraced by patients and physicians but are also associated with substantial higher costs. To ensure the affordability and accessibility of health care, an evaluation of the outcomes in relation to the costs is increasingly requested. However, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Seefat, Maarten R., Cucchi, David G. J., Dirven, Stijn, Groen, Kaz, Zweegman, Sonja, Blommestein, Hedwig M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615675/
https://www.ncbi.nlm.nih.gov/pubmed/34830761
http://dx.doi.org/10.3390/cancers13225606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615675/
https://www.ncbi.nlm.nih.gov/pubmed/34830761
http://dx.doi.org/10.3390/cancers13225606

Ejemplares similares